Clinical Trial Update: Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg in Fast Condition [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence trial comparing empagliflozin/metformin extended-release 25 mg/1000 mg to Synjardy XR 25 mg/1000 mg under fasted conditions; the study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin/metformin Extended-Release Tablet (empagliflozin/metformin extended-release)
• SYNJARDY XR (Empagliflozin, Metformin hydrochloride)

Snippet

Sponsor: Humanis Saglık Anonim Sirketi | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 1 | Status: COMPLETED